Publicaciones en las que colabora con Ignacio Trujillano Martín (22)

2005

  1. Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972

2002

  1. Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain

    Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667

  2. Activity of six quinolones against 226 recent clinical isolates of Streptococcus pyogenes with reduced susceptibility to ciprofloxacin [3]

    Journal of Antimicrobial Chemotherapy

  3. Segundo estudio multicéntrico de la sensibilidad in vitro a piperacilina-tazobactam

    Revista Espanola de Quimioterapia, Vol. 15, Núm. 2, pp. 169-175

2001

  1. Antimicrobial susceptibilities of 1,730 Haemophilus influenzae respiratory tract isolates in Spain in 1998-1999

    Antimicrobial Agents and Chemotherapy, Vol. 45, Núm. 11, pp. 3226-3228

2000

  1. Streptococcus pneumoniae in community-acquired respiratory tract infections in Spain: The impact of serotype and geographical, seasonal and clinical factors on its susceptibility to the most commonly prescribed antibiotics

    Journal of Antimicrobial Chemotherapy, Vol. 46, Núm. 4, pp. 557-564

1999

  1. Antimicrobial resistance of 1,113 Streptococcus pneumoniae isolates from patients with respiratory tract infections in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 2, pp. 357-359

  2. Antimicrobial resistance of 914 beta-hemolytic streptococci isolated from pharyngeal swabs in Spain: Results of a 1-year (1996-1997) multicenter surveillance study

    Antimicrobial Agents and Chemotherapy, Vol. 43, Núm. 1, pp. 178-180

1995

  1. INFECCIONES NOSOCOMIALES POR ANAEROBIOS

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 13, Núm. 7, pp. 429-434

  2. Multicenter Spanish study of ciprofloxacin susceptibility in gram-negative bacteria

    European Journal of Clinical Microbiology & Infectious Diseases, Vol. 14, Núm. 5, pp. 456-459

  3. Susceptibilities of Brucella melitensis isolates to clinafloxacin and four other new fluoroquinolones

    Antimicrobial Agents and Chemotherapy, Vol. 39, Núm. 5, pp. 1194-1195

1993

  1. In vitro activities of new macrolides and rifapentine against Brucella spp.

    Antimicrobial Agents and Chemotherapy

1991

  1. Lack of effective bactericidal activity of new quinolones against Brucella spp.

    Antimicrobial Agents and Chemotherapy

  2. Meropenem: In-vitro activity and kinetics of activity against organisms of the bacteroides fragilis group

    Journal of Antimicrobial Chemotherapy, Vol. 27, Núm. 5, pp. 599-606

1990

  1. In vitro activities of irloxacin and E-3846, two new quinolones

    Antimicrobial Agents and Chemotherapy, Vol. 34, Núm. 6, pp. 1262-1267

  2. Kinetics of antimicrobial activity of amoxicillin/clavulanic acid and metronidazole against β-lactamase-producing Bacteroides fragilis group

    Journal of Chemotherapy, Vol. 2, Núm. 1, pp. 11-16

1989

  1. Activity of CM-40874 against Enterobacter resistant to third generation cephalosporins.

    Journal of chemotherapy (Florence, Italy), Vol. 1, Núm. 4 Suppl, pp. 357-359

  2. In-vitro activity of two new oral β-lactams

    Journal of Antimicrobial Chemotherapy

  3. Kinetics of antimicrobial activity of Augmentin (amoxycillin/clavulanic acid) against the Bacteroides fragilis group

    Journal of Drug Development, Vol. 2, Núm. SUPPL. 1, pp. 33-36

  4. Kinetics of antimicrobial activity of amoxycillin/clavulanic acid against Bacteroides fragilis group.

    Journal of chemotherapy (Florence, Italy), Vol. 1, Núm. 4 Suppl, pp. 76-77